secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0001641172-25-016501
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs appoints Carolina Abenante as independent director effective June 20, 2025
--------------------------------------------------------------------------------

- Ms. Abenante will serve on Nominating and Corporate Governance Committee and as Chair of Compensation Committee.
- Her term expires July 18, 2025, at the annual meeting; she is nominated for election to a full term.
- She will be appointed to the Audit Committee effective July 19, 2025, subject to independence and financial literacy.
- Ms. Abenante is founder of NYIAX and holds multiple law degrees; she receives $48,000 annual retainer and equity participation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000164117225016501/0001641172-25-016501-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000164117225016501/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-016501

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer